During the Hematology Week organized by the Virgen de la Arrixaca University Clinical Hospital, the European project NANEMIAR was presented. This is a cutting-edge research initiative focused on addressing congenital anemia through innovative technologies. The project is led by Dr. Pérez Oliva from OcaILab (FFIS–IMIB), in close collaboration with t...
News & Events
In this interview Dr. Miguel Blanquer Blanquer (Hematologist at Hospital Clínico Universitario Virgen de la Arrixaca – Murcian Health Service) shares his clinical perspective on congenital anemias, the limitations of current treatments, and the hope represented by innovative approaches such as NANEMIAR. Murcian Health Service participates as Affili...
The Nanemiar research team played a particularly significant role in the 10th Conference of the Murcia Institute for Biomedical Research (IMIB), held yesterday in Murcia. This event, which has established itself as a key event for the regional and national scientific community, brings together researchers, technicians, and professionals linked to t...
Congenital anemias are genetic hematological diseases that affect the production or function of red blood cells. Although not widely known, they have a significant impact on the quality of life of those affected, especially during childhood and adolescence. The NANEMIAR project was created with the goal of promoting early diagnosis, research, and t...
The Rare Anaemias International Network (RAIN) Advisory Committee meeting was held on October 24th, 2025. The objective of this meeting was to bring together RAIN members, the RAIN Advisory Committee, and key partners to align on strategic priorities for 2025–2026, including updates on the RAIN/PKDIA Conference 2026, the RAIN AI Chatbot, gene thera...